Archer, T. M., D. M. Boothe, V. C. Langston, C. L. Fellman, K. V. Lunsford and A. J. Mackin (2014). “Oral cyclosporine treatment in dogs: a review of the literature.” J Vet Intern Med 28(1): 1-20.
Cosgrove, S. B., D. M. Cleaver, V. L. King, A. R. Gilmer, A. E. Daniels, J. A. Wren and M. R. Stegemann (2015). “Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.” Vet Dermatol 26(3): 171-179, e135.
Dip, R., J. Carmichael, I. Letellier, G. Strehlau, E. Roberts, E. Bensignor and W. Rosenkrantz (2013). “Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.” BMC Vet Res 9: 173.
Moyaert, H., L. Van Brussel, S. Borowski, M. Escalada, S. P. Mahabir, R. R. Walters and M. R. Stegemann (2017). “A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.” Vet Dermatol.
Olivry T (2017). An overview of monoclonal antibody therapy. Targeted therapy for Canine Atopic Dermatitis. . Symposium ESVD-ECVD Congress. Lausanne, Switzerland,.
Ortalda, C., C. Noli, S. Colombo and S. Borio (2015). “Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.” Vet Dermatol 26(4): 235-e252.
Thelen, A., R. S. Mueller, M. Linek, S. Peters, K. Stechmann and J. Steffan (2006). “Influence of food intake on the clinical response to cyclosporin A in canine atopic dermatitis.” Vet Rec 159(25): 854-856.